“This prospective, randomized, double-blinded trial compared outcomes in dogs with bilateral elbow osteoarthritis (OA) treated with hyaluronan plus methylprednisolone (HA + S) or autologous conditioned plasma (ACP(®); Arthrex).”
“These data provide some evidence to support use of either hyaluronan plus methylprednisolone acetate or autologous conditioned plasma alone or as an adjunct to other non-surgical or surgical treatment of elbow OA and may be particularly useful for patients which cannot tolerate other disease- modifying osteoarthritis drugs such as NSAIDs. The evidence for efficacy based upon these data are relatively weak because of the study limitations, but the lack of any complications is valuable in justifying their attempted use when other therapies have failed and in justifying further study of these products to more rigorously assess their benefits.”